VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
XYL
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
XYLXylem Inc.
$116.45$27.7B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksXYLQuarterly Financials

Xylem Inc. (XYL) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Xylem Inc. (XYL) quarterly income statement — complete revenue, gross profit & net income history

XYL Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23
Sales/Revenue2.13B2.4B2.27B2.3B2.07B2.26B2.1B2.17B2.03B2.12B2.08B1.72B
Revenue Growth %2.71%6.25%7.85%6.09%1.77%6.47%1.3%25.96%40.4%40.7%50.43%26.25%
Cost of Goods Sold1.32B1.47B1.39B1.41B1.3B1.4B1.32B1.35B1.28B1.36B1.31B1.07B
COGS % of Revenue62.21%61.12%61.07%61.23%62.88%62.01%62.72%62.29%62.96%64.18%63.2%62.2%
Gross Profit803M932M883M892M768M857M784M819M752M756M764M651M
Gross Margin %37.79%38.88%38.93%38.77%37.12%37.99%37.28%37.76%36.99%35.68%36.8%37.8%
Gross Profit Growth %4.56%8.75%12.63%8.91%2.13%13.36%2.62%25.81%37.73%31.94%45.8%25.19%
Operating Expenses559M579M549M587M537M590M504M566M543M545M573M532M
OpEx % of Revenue26.31%24.16%24.21%25.51%25.95%26.15%23.97%26.1%26.71%25.72%27.6%30.89%
Selling, General & Admin472M486M474M503M460M507M445M485M474M466M491M446M
SG&A % of Revenue22.21%20.28%20.9%21.86%22.23%22.47%21.16%22.36%23.32%21.99%23.65%25.9%
Research & Development56M60M52M58M56M58M55M58M59M60M61M58M
R&D % of Revenue2.64%2.5%2.29%2.52%2.71%2.57%2.62%2.67%2.9%2.83%2.94%3.37%
Other Operating Expenses1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K
Operating Income244M353M334M305M231M267M280M253M209M211M191M119M
Operating Margin %11.48%14.73%14.73%13.26%11.16%11.84%13.31%11.66%10.28%9.96%9.2%6.91%
Operating Income Growth %5.63%32.21%19.29%20.55%10.53%26.54%46.6%112.61%59.54%7.11%13.69%-18.49%
EBITDA384M496M475M450M376M409M421M398M343M348M338M211M
EBITDA Margin %18.07%20.69%20.94%19.56%18.17%18.13%20.02%18.35%16.87%16.42%16.28%12.25%
EBITDA Growth %2.13%21.27%12.83%13.07%9.62%17.53%24.56%88.63%79.58%35.41%49.56%2.43%
D&A (Non-Cash Add-back)140M143M141M145M145M142M141M145M134M137M147M92M
EBIT248M374M303M308M225M384M279M258M210M224M199M126M
Net Interest Income-4M-6M-6M-9M-8M-9M-10M-11M-14M-14M-14M-12M
Interest Income000000000000
Interest Expense4M6M6M9M8M9M10M11M14M14M14M12M
Other Income/Expense015M-37M-6M-14M108M-11M-6M-13M-1M-6M-5M
Pretax Income244M368M297M299M217M375M269M247M196M210M185M114M
Pretax Margin %11.48%15.35%13.1%12.99%10.49%16.62%12.79%11.39%9.64%9.91%8.91%6.62%
Income Tax55M35M71M75M50M49M52M53M43M-56M33M22M
Effective Tax Rate %22.54%9.51%23.91%25.08%23.04%13.07%19.33%21.46%21.94%-26.67%17.84%19.3%
Net Income185M335M227M226M169M326M217M194M153M266M152M92M
Net Margin %8.71%13.98%10.01%9.82%8.17%14.45%10.32%8.94%7.53%12.55%7.32%5.34%
Net Income Growth %9.47%2.76%4.61%16.49%10.46%22.56%42.76%110.87%54.55%78.52%1166.67%-17.86%
Net Income (Continuing)189M333M226M224M167M326M217M194M153M266M152M92M
Discontinued Operations000000000000
Minority Interest257M269M238M235M238M240M7M7M8M10M11M11M
EPS (Diluted)0.791.370.930.930.691.340.890.800.631.100.630.45
EPS Growth %14.49%2.24%4.49%16.25%9.52%21.82%41.27%77.78%14.55%34.15%850.23%-27.42%
EPS (Basic)0.791.370.930.930.701.340.890.800.631.100.630.45
Diluted Shares Outstanding243.36M244M244.1M243.86M243.8M243.8M243.75M243.54M243.02M241.5M242.19M206.74M
Basic Shares Outstanding242.76M243.4M243.5M243.37M243.1M243.8M243.75M242.57M241.85M241.5M240.87M205.54M
Dividend Payout Ratio57.3%29.25%42.73%43.36%57.99%26.69%40.55%44.85%57.52%30.08%52.63%85.87%